What was studied?
A small randomized rat tendon-transection study compared control, individual interventions and their combination over four weeks.
What did the researchers report?
Selected histology findings improved; the reported biomechanical advantage was clearest for the TB-500-labeled group. The combination did not show an additive effect.
What are the limits?
The short exploratory model does not establish human tendon recovery. The paper's peptide naming must be checked against actual sequence and formulation before linking it to any catalog blend.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.